INS and type 1 diabetes mellitus: Insulin pump therapy in type 1 diabetes is associated with improvement in hemoglobin A1C (HbA1C) and reduction in episodes of severe hypoglycemia and diabetic ketoacidosis (DKA) [6,7,9,11].